Efficacy and Safety of Apatinib Plus Vinorelbine in Patients With Wild-Type Advanced Non–Small Cell Lung Cancer After Second-Line Treatment Failure
JAMA network open - United States
doi 10.1001/jamanetworkopen.2020.1226
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 19, 2020
Authors
Publisher
American Medical Association (AMA)